Enabling equitable open access to commercially funded research publications
PLOS Medicine · 2026
DOI: 10.1371/journal.pmed.1005207 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Medicine, 2026. Verfasst von Anja Schmidt und 4 weiteren Autor:innen. Beteiligte Einrichtung: Takeda Development Center Americas, Inc., Cambridge, Massachusetts, United States of America. Hauptthemen laut MEDLINE: Biomedical Research, Open Access Publishing, Drug Industry, Periodicals as Topic. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pharmaceutical companies fund much biomedical research, yet many journals restrict open access publishing options for peer-reviewed articles reporting commercially funded research. Expanded publishing options, such as funder-neutral publishing policies, will help address this inequity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Takeda Development Center Americas, Inc., Cambridge, Massachusetts, United States of America.
- Oxford PharmaGenesis, Oxford, United Kingdom.
- Pfizer, New York, New York, United States of America.
- Eli Lilly and Company, Indianapolis, Indiana, United States of America.
- Scripps Research, La Jolla, California, United States of America.
ORCID-Profile: Anja Schmidt, Christopher C Winchester, Catherine Skobe, Diane R Stothard
Zitieren
APA
Schmidt, A., Winchester, C. C., Skobe, C., Stothard, D. R., & Topol, E. (2026). Enabling equitable open access to commercially funded research publications. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1005207
Vancouver
Schmidt A, Winchester CC, Skobe C, Stothard DR, Topol E. Enabling equitable open access to commercially funded research publications. PLOS Medicine. 2026. doi:10.1371/journal.pmed.1005207
BibTeX
@article{Schmidt2026,
author = {Schmidt, Anja and Winchester, Christopher C and Skobe, Catherine and Stothard, Diane R and Topol, Eric},
title = {Enabling equitable open access to commercially funded research publications},
journal = {PLOS Medicine},
year = {2026},
doi = {10.1371/journal.pmed.1005207}
}
EUVIMED